Réanimation médicale, Hôpital central, CHU Nancy, France.
Réanimation médicale, Hôpital central, CHU Nancy, France.
Intensive Crit Care Nurs. 2020 Oct;60:102881. doi: 10.1016/j.iccn.2020.102881. Epub 2020 Jun 1.
Intensive care unit patients undergo several nursing care procedures (NCP) every day. These procedures involve a risk for adverse events (AE). Yet, their prevalence, intensity, and predisposing risk factors remain poorly established. The main objective of the study was to measure the incidence and severity of NCP related AE.
This prospective observational multicentre study was conducted in 9 ICUs. All NCP were recorded for four consecutive weeks. For each NCP, the following were collected: patients' baseline characteristics, type of NCP, characteristics of the NCP, AE and therapeutic responses.
5849 NCP occurred in 340 patients. Among the 340 patients included, 292 (85.9%) were affected by at least one AE, and 141 (41.5%) by an SAE during a NCP. Thirty % of NCP were associated with at least one AE: hemodynamic AE in 17.1%, respiratory AE in 13.6%, agitation and pain (3.7% and 3.3%). Eight invasive devices were accidentally removed. Severe Adverse Events (SAE) occurred in 5.5% of NCP. The main risk factor associated with SAE was pain/agitation at the beginning of the NCP.
AE are frequent during NCP in ICU. We identified several risk factors, some of them preventable, that could be considered for the development of recommendations for the nursing care of critically ill patients.
ClinicalTrials.gov NCT02881645.
重症监护病房(ICU)患者每天接受多项护理操作(NCP)。这些操作可能导致不良事件(AE)。然而,其发生率、强度和易患风险因素仍未得到充分确定。本研究的主要目的是测量与 NCP 相关的 AE 的发生率和严重程度。
这是一项前瞻性观察性多中心研究,在 9 家 ICU 进行。连续四周记录所有 NCP。对于每一项 NCP,采集以下信息:患者的基线特征、NCP 的类型、NCP 的特征、AE 和治疗反应。
340 名患者共发生 5849 项 NCP。在纳入的 340 名患者中,292 名(85.9%)至少发生了一次 AE,141 名(41.5%)在 NCP 期间发生了严重不良事件(SAE)。30%的 NCP 与至少一次 AE 相关:血流动力学 AE 占 17.1%,呼吸系统 AE 占 13.6%,躁动和疼痛分别占 3.7%和 3.3%。有 8 个侵入性设备意外被移除。5.5%的 NCP 发生了严重不良事件(SAE)。与 SAE 相关的主要危险因素是 NCP 开始时的疼痛/躁动。
AE 在 ICU 患者的 NCP 中很常见。我们确定了一些风险因素,其中一些是可以预防的,可以考虑为危重症患者的护理制定建议。
ClinicalTrials.gov NCT02881645。